1,2-dimethylhydrazine increases expression ISO RGD:1550332 6480464 1, 2-Dimethylhydrazine results in increased expression of FAM65B mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:1315839 6480464 Ethinyl Estradiol results in decreased expression of RIPOR2 mRNA CTD PMID:18936297 17beta-estradiol multiple interactions ISO RGD:1315839 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of RIPOR2 mRNA CTD PMID:22217510 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPOR2 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPOR2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1315839 6480464 Tetrachlorodibenzodioxin results in decreased expression of RIPOR2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPOR2 mRNA CTD PMID:33387578 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550332 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RIPOR2 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases expression ISO RGD:1550332 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of FAM65B mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:1550332 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FAM65B gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:1550332 6480464 Fenretinide results in increased expression of RIPOR2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RIPOR2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FAM65B mRNA CTD PMID:30047161 8-Br-cAMP increases expression ISO RGD:1315839 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPOR2 mRNA CTD PMID:20147733 acetamide increases expression EXP 6480464 acetamide results in increased expression of RIPOR2 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1315839 6480464 Acrylamide results in decreased expression of RIPOR2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1315839 6480464 Aflatoxin B1 results in increased expression of RIPOR2 mRNA CTD PMID:21641981 aflatoxin B1 increases methylation ISO RGD:1315839 6480464 Aflatoxin B1 results in increased methylation of RIPOR2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1550332 6480464 Aflatoxin B1 results in decreased expression of RIPOR2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1315839 6480464 Aflatoxin B1 results in decreased methylation of FAM65B intron, Aflatoxin B1 results in decreased methylation of RIPOR2 gene CTD PMID:27153756 , PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1315839 6480464 Tretinoin results in decreased expression of RIPOR2 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1315839 6480464 Tretinoin results in increased expression of FAM65B mRNA CTD PMID:33167477 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein CTD PMID:34896426 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of FAM65B mRNA CTD PMID:30047161 amphotericin B decreases expression ISO RGD:1315839 6480464 Amphotericin B analog results in decreased expression of FAM65B mRNA, Amphotericin B results in decreased expression of FAM65B mRNA CTD PMID:28534445 antirheumatic drug decreases expression ISO RGD:1315839 6480464 Antirheumatic Agents results in decreased expression of RIPOR2 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:1315839 6480464 Arsenic Trioxide results in decreased expression of FAM65B mRNA CTD PMID:26705709 benzo[a]pyrene decreases expression ISO RGD:1550332 6480464 Benzo(a)pyrene results in decreased expression of RIPOR2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1315839 6480464 Benzo(a)pyrene affects the methylation of FAM65B 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550332 6480464 Benzo(a)pyrene results in increased expression of RIPOR2 mRNA CTD PMID:32417428 Benzo[k]fluoranthene increases expression ISO RGD:1550332 6480464 benzo(k)fluoranthene results in increased expression of RIPOR2 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1315839 6480464 Diethylhexyl Phthalate results in increased expression of FAM65B mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1315839 6480464 bisphenol A affects the expression of RIPOR2 mRNA CTD PMID:20170705 bisphenol A multiple interactions ISO RGD:1315839 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPOR2 gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FAM65B gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RIPOR2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1315839 6480464 bisphenol A results in decreased expression of RIPOR2 mRNA CTD PMID:25047013 bisphenol F decreases expression ISO RGD:1550332 6480464 bisphenol F results in decreased expression of FAM65B mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:1550332 6480464 1, 3-butadiene results in decreased expression of FAM65B mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1315839 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FAM65B mRNA CTD PMID:29432896 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of RIPOR2 mRNA CTD PMID:25993096 carbamazepine affects expression ISO RGD:1315839 6480464 Carbamazepine affects the expression of RIPOR2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1550332 6480464 Nanotubes, Carbon analog results in decreased expression of RIPOR2 mRNA CTD PMID:25554681 chloroprene decreases expression ISO RGD:1550332 6480464 Chloroprene results in decreased expression of RIPOR2 mRNA CTD PMID:23125180 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of RIPOR2 mRNA CTD PMID:24386269 cyclosporin A decreases expression ISO RGD:1315839 6480464 Cyclosporine results in decreased expression of RIPOR2 mRNA CTD PMID:20106945 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein CTD PMID:34896426 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein CTD PMID:34896426 dexamethasone increases expression ISO RGD:1315839 6480464 Dexamethasone results in increased expression of RIPOR2 mRNA CTD PMID:12782123 diarsenic trioxide decreases expression ISO RGD:1315839 6480464 Arsenic Trioxide results in decreased expression of FAM65B mRNA CTD PMID:26705709 dimethylarsinic acid multiple interactions ISO RGD:1550332 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA CTD PMID:34876320 diuron increases expression EXP 6480464 Diuron results in increased expression of RIPOR2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1315839 6480464 entinostat results in increased expression of RIPOR2 mRNA CTD PMID:26272509 ethanol affects splicing ISO RGD:1550332 6480464 Ethanol affects the splicing of FAM65B mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1315839 6480464 Ethyl Methanesulfonate results in decreased expression of RIPOR2 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of RIPOR2 mRNA CTD PMID:30307764 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein CTD PMID:34896426 fipronil increases expression EXP 6480464 fipronil results in increased expression of RIPOR2 mRNA CTD PMID:34044035 folic acid decreases expression ISO RGD:1550332 6480464 Folic Acid results in decreased expression of FAM65B mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1315839 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPOR2 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of RIPOR2 mRNA CTD PMID:26194646 genistein decreases expression ISO RGD:1315839 6480464 Genistein results in decreased expression of RIPOR2 mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RIPOR2 mRNA CTD PMID:22061828 , PMID:33387578 isobutanol multiple interactions ISO RGD:1315839 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FAM65B mRNA CTD PMID:29432896 melphalan decreases expression ISO RGD:1315839 6480464 Melphalan results in decreased expression of RIPOR2 mRNA CTD PMID:22363485 mercury dibromide increases expression ISO RGD:1315839 6480464 mercuric bromide results in increased expression of RIPOR2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of RIPOR2 mRNA CTD PMID:19564919 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of FAM65B mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO RGD:1315839 6480464 Methyl Methanesulfonate results in decreased expression of RIPOR2 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:1550332 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA CTD PMID:34876320 methylmercury chloride increases expression ISO RGD:1315839 6480464 methylmercuric chloride results in increased expression of RIPOR2 mRNA CTD PMID:28001369 N-nitrosodiethylamine decreases expression ISO RGD:1550332 6480464 Diethylnitrosamine results in decreased expression of RIPOR2 mRNA CTD PMID:24535843 nickel atom decreases expression ISO RGD:1315839 6480464 Nickel results in decreased expression of RIPOR2 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1315839 6480464 Nickel results in increased expression of RIPOR2 mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RIPOR2 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of RIPOR2 mRNA CTD PMID:28623178 ozone multiple interactions ISO RGD:1550332 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RIPOR2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RIPOR2 mRNA CTD PMID:34911549 paracetamol decreases expression ISO RGD:1315839 6480464 Acetaminophen results in decreased expression of FAM65B mRNA CTD PMID:29067470 perfluorononanoic acid decreases expression ISO RGD:1315839 6480464 perfluoro-n-nonanoic acid results in decreased expression of RIPOR2 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1550332 6480464 Phenobarbital affects the expression of RIPOR2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1315839 6480464 Phenylmercuric Acetate results in increased expression of RIPOR2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA CTD PMID:27188386 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of FAM65B mRNA CTD PMID:30047161 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of RIPOR2 protein CTD PMID:34896426 raloxifene multiple interactions ISO RGD:1315839 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of RIPOR2 mRNA CTD PMID:19059307 resveratrol decreases expression ISO RGD:1315839 6480464 resveratrol results in decreased expression of RIPOR2 mRNA CTD PMID:12002526 rotenone increases expression EXP 6480464 Rotenone results in increased expression of RIPOR2 protein CTD PMID:35544339 SB 431542 multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1550332 6480464 Silver results in decreased expression of RIPOR2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1550332 6480464 Silver results in decreased expression of RIPOR2 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1550332 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1315839 6480464 sodium arsenite results in decreased expression of RIPOR2 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:1550332 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA CTD PMID:34876320 sunitinib decreases expression ISO RGD:1315839 6480464 Sunitinib results in decreased expression of RIPOR2 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:1315839 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of RIPOR2 mRNA CTD PMID:19059307 temozolomide increases expression ISO RGD:1315839 6480464 Temozolomide results in increased expression of RIPOR2 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPOR2 mRNA CTD PMID:32741896 tetraphene increases expression ISO RGD:1550332 6480464 benz(a)anthracene results in increased expression of RIPOR2 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RIPOR2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RIPOR2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RIPOR2 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1315839 6480464 trichostatin A results in increased expression of RIPOR2 mRNA CTD PMID:24935251 triptonide increases expression ISO RGD:1550332 6480464 triptonide results in increased expression of RIPOR2 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1550332 6480464 Tungsten results in decreased expression of FAM65B mRNA CTD PMID:30912803 valproic acid decreases methylation ISO RGD:1315839 6480464 Valproic Acid results in decreased methylation of FAM65B gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1315839 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1315839 6480464 Valproic Acid results in increased expression of RIPOR2 mRNA CTD PMID:23179753 more ...
